¼¼°èÀÇ °í¾È¾ÐÁõ Ä¡·á ½ÃÀå - »ê¾÷±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, À¯Çüº°, Åõ¿©°æ·Îº°, À¯Åëä³Îº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Ocular Hypertension Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Route Of Administration, By Distribution Channel, By Region & Competition, 2020-2030F
»óǰÄÚµå : 1692270
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 185 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,957,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,575,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°í¾È¾ÐÁõ Ä¡·á ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 36¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2030³â±îÁöÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 3.82%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÃÖ±Ù, °í¾È¾ÐÁõÀÇ À¯º´·üÀÌ »ó½ÂÇϰí Áøº¸µÈ Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ´Â °ÍÀ» ¹è°æÀ¸·Î, ÀÌ ½ÃÀåÀº Å« ¹ßÀüÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. °í¾È¾ÐÁõÀº ¾È¾ÐÀÇ »ó½ÂÀ» Ư¡À¸·Î ÇÏ¸ç ¹æÄ¡ÇÏ¸é ³ì³»Àå¿¡ À̸¦ ¼ö ÀÖÀ¸¸ç ¼¼°èÀûÀ¸·Î µ¹ÀÌų ¼ö ¾ø´Â ½Ç¸íÀÇ ÁÖ¿ä ¿øÀÎ Áß Çϳª°¡ µÇ°í ÀÖ½À´Ï´Ù. ±× °á°ú, °í¾È¾Ð Ä¡·á ½ÃÀåÀº ¾È°ú ÀÇ·á ºÐ¾ßÀÇ Áß¿äÇÑ ºÎ¹®ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 1¿ù, Àεð¾Ö³ª ´ëÇÐ Àǰú ´ëÇÐÀÇ ¿¬±¸ÀÚµéÀº ³ì³»ÀåÀÇ È¹±âÀûÀÎ Ä¡·á¹ýÀ» °³¹ßÇÏ´Â Çõ½ÅÀûÀÎ ÀÌ´Ï¼ÅÆ¼ºê¸¦ ½ÃÀÛÇß½À´Ï´Ù. ÀÌ ¿¬±¸´Â ¹Ì±¹ ±¹¸³ ¾Èº´ ¿¬±¸¼Ò·ÎºÎÅÍ 200¸¸ ´Þ·¯ÀÇ R01 º¸Á¶±ÝÀ» ¹Þ¾Ò½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 36¾ï 7,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 45¾ï 6,000¸¸ ´Þ·¯
CAGR : 2025-2030³â 3.82%
±Þ¼ºÀå ºÎ¹® ¿Â¶óÀÎ ¾à±¹
ÃÖ´ë ½ÃÀå ºÏ¹Ì

ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

³ëÈ­

ÁÖ¿ä ½ÃÀå °úÁ¦

°ú¼Ò Áø´Ü ¹× ÀÎ½Ä ºÎÁ·

ÁÖ¿ä ½ÃÀå µ¿Çâ :

³·Àº ħ½À ¼ö¼ú ±â¼ú

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼¼°èÀÇ °í¾È¾ÐÁõ Ä¡·á ½ÃÀå Àü¸Á

Á¦5Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °í¾È¾ÐÁõ Ä¡·á ½ÃÀå Àü¸Á

Á¦6Àå À¯·´ÀÇ °í¾È¾ÐÁõ Ä¡·á ½ÃÀå Àü¸Á

Á¦7Àå ºÏ¹ÌÀÇ °í¾È¾ÐÁõ Ä¡·á ½ÃÀå Àü¸Á

Á¦8Àå ³²¹ÌÀÇ °í¾È¾ÐÁõ Ä¡·á ½ÃÀå Àü¸Á

Á¦9Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °í¾È¾ÐÁõ Ä¡·á ½ÃÀå Àü¸Á

Á¦10Àå ½ÃÀå ¿ªÇÐ

Á¦11Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦12Àå ¼¼°èÀÇ °í¾È¾ÐÁõ Ä¡·á ½ÃÀå : SWOT ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

Á¦15Àå Àü·«Àû Á¦¾È

Á¦16Àå ±â¾÷ ¼Ò°³¿Í ¸éÃ¥»çÇ×

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global Ocular Hypertension Treatment Market was valued at USD 3.67 billion in 2024 and is projected to experience robust growth during the forecast period, with a compound annual growth rate (CAGR) of 3.82% through 2030. The market has seen significant development in recent years, driven by the rising prevalence of ocular hypertension and the increasing demand for advanced therapeutic solutions. Ocular hypertension is characterized by elevated intraocular pressure, which, if left untreated, can lead to glaucoma-one of the leading causes of irreversible blindness worldwide. As a result, the ocular hypertension treatment market is a critical segment of the ophthalmic healthcare sector. For example, in January 2024, researchers at Indiana University School of Medicine launched an innovative initiative to develop groundbreaking therapy for glaucoma, supported by a USD 2 million R01 grant from the National Eye Institute.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.67 Billion
Market Size 2030USD 4.56 Billion
CAGR 2025-20303.82%
Fastest Growing SegmentOnline Pharmacy
Largest MarketNorth America

Key Market Drivers:

Aging Population

The growing aging population is a key driver of the expanding global ocular hypertension treatment market. As individuals age, they become more susceptible to ocular hypertension due to age-related changes in the eye's drainage system, which can hinder the flow of aqueous humor and increase intraocular pressure. The World Health Organization forecasts that the global population aged 60 and older will more than double by 2050, reaching nearly 2.1 billion people. This demographic shift will result in a rise in the prevalence of ocular hypertension and glaucoma among the elderly, creating a larger patient base in need of treatment. As the population ages, there will be an increased demand for both pharmaceutical and surgical interventions, including minimally invasive procedures like Micro-Invasive Glaucoma Surgery (MIGS). These treatments offer less invasive and more efficient solutions for managing intraocular pressure. Consequently, the global ocular hypertension treatment market is positioned for steady growth, catering to the rising healthcare needs of older individuals and contributing to better vision preservation and reduced blindness rates.

Key Market Challenges:

Underdiagnosis and Lack of Awareness

Ocular hypertension is often a silent condition, with no obvious symptoms, making it challenging to detect early. Many individuals are unaware of the condition and its potential progression to glaucoma, which leads to a delay in diagnosis and intervention. This lack of awareness poses a significant barrier to market growth, as untreated ocular hypertension can advance to glaucoma, resulting in irreversible vision loss. Public ignorance about the importance of regular eye check-ups further complicates early detection efforts. Raising awareness about ocular hypertension and its connection to glaucoma is essential for capturing potential patients early, when treatments are most effective. Healthcare professionals, ophthalmologists, and public health campaigns must play a key role in educating individuals about the risks of ocular hypertension and the need for proactive eye care.

Key Market Trends:

Minimally Invasive Surgical Techniques

Minimally invasive surgical techniques are transforming the treatment landscape for ocular hypertension. Traditionally, managing elevated intraocular pressure involved more invasive surgeries, often with longer recovery times and higher risks. However, the development of Micro-Invasive Glaucoma Surgery (MIGS) has introduced a less invasive approach that reduces surgical trauma while targeting the underlying causes of elevated intraocular pressure. MIGS has numerous benefits for both patients and healthcare providers, including shorter recovery periods, lower complication rates, and improved patient outcomes. The growing adoption of MIGS is expected to continue driving the ocular hypertension treatment market, providing a shift toward more efficient and patient-friendly treatment options.

Key Market Players:

Report Scope:

This report segments the global ocular hypertension treatment market into various categories and provides a detailed analysis of trends:

By Type:

By Route of Administration:

By Distribution Channel:

By Region:

Competitive Landscape:

This section provides a comprehensive analysis and profiling of major companies operating in the global ocular hypertension treatment market.

Available Customizations:

TechSci Research offers tailored customization options for this market report, allowing adjustments to meet specific company needs. Customization options include detailed analysis and profiling of up to five additional market players.

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global Ocular Hypertension Treatment Market Outlook

5. Asia Pacific Ocular Hypertension Treatment Market Outlook

6. Europe Ocular Hypertension Treatment Market Outlook

7. North America Ocular Hypertension Treatment Market Outlook

8. South America Ocular Hypertension Treatment Market Outlook

9. Middle East and Africa Ocular Hypertension Treatment Market Outlook

10. Market Dynamics

11. Market Trends & Developments

12. Global Ocular Hypertension Treatment Market: SWOT Analysis

13. Porter's Five Forces Analysis

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â